Wellthy Therapeutics, a Mumbai-based Digital Therapeutics company, has launched digital therapeutics, an mobile application (app) in Hindi and Kannada languages. This mobile app can be used by patients for seeking doctors’ consultation on cardiovascular conditions and diabetes in both languages. This app is recommended by a doctor. Around 50 doctors are associated with Wellthy Therapeutics.
Mr Abhishek Shah, CEO and Co-Founder, Wellthy Therapeutics, said that delivering health outcomes using digital therapeutics allows Wellthy Therapeutics the unique privilege of designing for the patient first.
“While incredible strides have and will continue to be made on our therapeutic capability in diabetes and cardiology, we have embarked on a powerful journey using the native language,” said Mr Shah.
Mr Shah added, “Expanding our Made in India effort to Made for Bharat, we continue our march towards empowering and enabling patients to manage their chronic conditions better, by meeting users’ needs in their cultural setting, in their language of choice.”
Dr Rajeev Chawla, President, Research Society for the Study of Diabetes in India, said “Chronic disease management must be driven by solutions built around lifestyle modification methods and monitoring methods. Wellthy’s move to speak with users in a language they understand will have high applicability and shall drive manifold benefit by easing the growing disease burden through empowerment.”